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Biotech: Not Just for Geeks
Business students get high marks for scientific literacy
Fred Ledley
November 20, 2019
In a down economy, biotechnology jobs are growing faster than the overall
Massachusetts state economy. The numbers don’t lie, says a recent
industry study:



More than 53,000 people in the Bay State are employed in the
biopharmaceutical industry
More than 28,000 people in biotechnology collectively earn more than
$6 billion per year

These are big numbers. They reflect the state’s leading role in an industry that
comprises more than 70,000 establishments, employs more than 1.5 million
people nationwide, and continues to grow, according to the Massachusetts
Biotechnology Council.
But there’s a more important observation. The Massachusetts biotechnology
industry is maturing, with several important new drugs launched in the past
year and 10 more awaiting FDA approval. As it advances, its workforce needs
are changing. And it goes well beyond science geeks.
Between 2010 and 2011, the greatest job growth in the biotech industry
occurred on the business side: finance and administration, operations,
business development, and quality. Sure, start-up biotechnology companies
are fueled by scientific minds, but by the time biopharmaceutical companies
successfully bring their products to market, the majority of the workforce is
engaged in business functions such as general and administrative and
marketing.
Far too often, these are hard positions for companies to fill. In addition to
outstanding business skills, it takes an interdisciplinary knowledge of science
as it is applied in a business context. In biotechnology, science and

technology must be closely integrated with corporate and business strategy.
Business professionals have a critical role in shaping the direction of research
and development to align with the company’s business model and strategy as
well as establishing the goals, staffing, and budget for the company’s
technical functions.
This does not suggest that business professionals need to be able to do
science or even be expert in their company’s technologies. But they do need
to know how to understand the nature of science and technology, the process
of technology innovation and implementation, and the strategic role of
technology in business. In a word, business professionals need to be
scientifically literate.
The National Academies of Science have defined scientific literacy as “the
knowledge and understanding of scientific concepts and processes required
for personal decision making, participation in civic and cultural affairs, and
economic productivity.” Others have defined scientific literacy as the ability to
understand articles at the level of the New York Times Science Times section
— a level arguably close to the typical biotechnology business plan or annual
report — or the ability to “understand the scientific issue of our times.”
In fact, less than one-third of Americans achieve these levels of scientific
literacy. This is a problem for industries like biotechnology that are critically
dependent not only on a workforce of scientists, engineers, technicians and
clinicians, but also on business professionals with the interdisciplinary skills in
science, technology, and business to manage, invest in, and lead their
enterprise. As a result, employers routinely emphasize the need for a greater
focus on science and technology in the undergraduate curriculum.
We recently completed a survey of leading business schools, and found that
80 percent of these schools require science courses as part of their
undergraduate curriculum. Our study also found, however, that very few
schools have designed courses explicitly tailored to business students.
The number of undergraduate science courses has been shown to be the
single strongest predictor of scientific literacy. Courses designed to prepare
students with an interdisciplinary knowledge of science and business

applications could become a similarly strong predictor of professional success
in growing, technology-driven industries like biotechnology.
Biotechnology is not just for characters like Dr. Amy Farrah Fowler, a
neurobiologist on the popular sitcom Big Bang Theory, and a quintessential
science geek. But, characters like her have started companies that are rapidly
maturing, creating new opportunities for business professionals who are
prepared.
Fred Ledley is professor of natural and applied sciences and professor of
management, and director of the Center for Integration of Science and
Industry at Bentley University.

